Armata Pharmaceuticals, Inc.
ARMP · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $107,954 | $68,768 | $52,830 | $66,939 |
| - Cash | $14,756 | $4,328 | $11,688 | $9,291 |
| + Debt | $114,354 | $110,510 | $134,658 | $126,515 |
| Enterprise Value | $207,552 | $174,950 | $175,800 | $184,163 |
| Revenue | $1,159 | $2,169 | $491 | $1,235 |
| % Growth | -46.6% | 341.8% | -60.2% | – |
| Gross Profit | $789 | $1,803 | $114 | $855 |
| % Margin | 68.1% | 83.1% | 23.2% | 69.2% |
| EBITDA | -$21,959 | -$12,121 | -$2,552 | $6,260 |
| % Margin | -1,894.7% | -558.8% | -519.8% | 506.9% |
| Net Income | -$26,675 | -$16,295 | -$6,531 | $2,600 |
| % Margin | -2,301.6% | -751.3% | -1,330.1% | 210.5% |
| EPS Diluted | -0.74 | -0.45 | -0.18 | 0.044 |
| % Growth | -64.4% | -150% | -509.1% | – |
| Operating Cash Flow | -$4,298 | -$7,211 | -$7,580 | -$7,927 |
| Capital Expenditures | -$242 | -$149 | -$99 | $77 |
| Free Cash Flow | -$4,540 | -$7,360 | -$7,679 | -$7,850 |